Question 1

What is LOPJLB’s current signal on PLX?

Accepted Answer

LOPJLB’s latest quantitative signal on Protalix BioTherapeutics, Inc. (PLX) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is PLX in?

Accepted Answer

Protalix BioTherapeutics, Inc. (PLX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Protalix BioTherapeutics, Inc. (PLX) do?

Accepted Answer

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also…

Question 4

Where is Protalix BioTherapeutics, Inc. based / listed?

Accepted Answer

Protalix BioTherapeutics, Inc. is based in US, listed on AMEX.

Protalix BioTherapeutics, Inc. (PLX)

Key stats

Industry peers

Prediction markets

Company news